Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Status
- RECRUITING
- Phase
- PHASE2
Registry for Stage 2 Type 1 Diabetes
- Status
- RECRUITING
- Phase
- N/A
A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
- Status
- RECRUITING
- Phase
- PHASE3